Techniques for Respiratory Disorders - Advances in the Diagnosis and Evaluation of Disabling Physical Health Conditions

Share

Summary

An overview of new and improved diagnostic and evaluative techniques for respiratory disorders, their clinical applications, and their role in assessing disability.

Techniques for Respiratory Disorders - Advances in the Diagnosis and Evaluation of Disabling Physical Health Conditions

Highlights

Overview and Pulmonary Function Testing

Respiratory diseases like COPD and asthma are major causes of death and disability. Diagnostic evaluation begins with a clinical history and physical examination, followed by Pulmonary Function Testing (PFT). Recent advancements in PFT include standardized normative values that account for diverse populations rather than relying on fixed percentage adjustments for different ethnic groups.

Respiratory Diagnostic Techniques

Key diagnostic techniques include High-Resolution Computed Tomography (HRCT) for detailed lung imaging, Cardiopulmonary Exercise Testing (CPET) for assessing exercise-limiting conditions, and Bronchoprovocation Testing for identifying bronchial hyper-reactivity. Functional assessment tools like the 6-Minute Walk Test (6MWT) and the Modified Medical Research Council (mMRC) Dyspnea Scale provide objective measures of functional impact that resting lung tests alone may miss.

Composite Scoring and Indirect Assessment

The BODE Index is a widely used multidimensional instrument for COPD that combines BMI, airflow obstruction (FEV1), dyspnea, and exercise capacity to better predict mortality and disease burden compared to single variables. Other techniques like Endobronchial Ultrasound (EBUS), Video-Assisted Thoracic Surgery (VATS), and Positron Emission Tomography (PET) are essential for staging and diagnosing malignancies and complex lung conditions, though their direct impact on functional disability assessment varies.

Emerging Techniques

Emerging approaches include the Forced Oscillation Technique (useful for patients who struggle with standard maneuver-based testing), the Asthma Severity Scoring System (ASSESS) for multi-dimensional asthma tracking, and the use of cell-free DNA ('liquid biopsy') for identifying biomarkers for pulmonary arterial hypertension and other conditions.

Recently Summarized Articles

Loading...